We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Premier Research Biostatistician Receives Doctorate in Biostatistics for Advanced Survival Models in Oncology Clinical Trials


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Premier Research Biostatistician Receives Doctorate in Biostatistics for Advanced Survival Models in Oncology Clinical Trials"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 
Premier Research Group Limited, an international CRO with considerable oncology research expertise, announces that Dr. Liddy Chen has received a Doctorate degree in Biostatistics, focusing on study design issues in advanced survival models with major application to oncology clinical trials, from University of North Carolina at Chapel Hill.

Her research allows her to provide quality consultation services to clients, particularly in oncology studies. In addition to her ability to analyze data using complex survival models, she is able to assist clients with developing the most cost effective trial design so that maximum power can be achieved with the same number of subjects.

Dr. Chen’s research compliments Premier Research’s oncology focus. Premier Research has extensive experience in all major types of cancers and this depth of experience means that Premier Research’s staff across all functional areas have a thorough understanding and familiarity with the tasks required to successfully manage and analyze oncology studies.

“We are very proud of Dr. Chen’s recent accomplishments and are fortunate to have her as a part of our advanced oncology team,” said Tara Fitzgerald, Vice President, Global Biometrics. “Liddy has been instrumental in strengthening our organization as a premier provider of clinical study design in the area of oncology.”

Dr. Chen also holds a Doctor of Medicine degree from the Sun Yet-Sen University of Medical Sciences and a Master of Science degree in Epidemiology and Biostatistics from the University of Western Ontario. Dr. Chen has more than 15 years of experience in a variety of applied settings, including the pharmaceutical and CRO industries, with primary expertise in oncology trials.
Advertisement